
0.8181 Delayed Data As of 3:57pm ET | ![]() Today’s Change | 0.53 Today|||52-Week Range 9.09 | -89.79% Year-to-Date |
The 6 analysts offering 12-month price forecasts for ProQR Therapeutics NV have a median target of 1.23, with a high estimate of 3.94 and a low estimate of 0.78. The median estimate represents a +50.78% increase from the last price of 0.82.
The current consensus among 8 polled investment analysts is to Hold stock in ProQR Therapeutics NV. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.